Originally posted on July 23, 2025 • Last updated September 12, 2025 • Last reviewed October 1, 2025 There is currently a drug shortage of Penicillin G benzathine injectable suspension products (Bicillin L-A®) due to a manufacturer’s voluntary recall (1, 2, 3, 4, 5). This penicillin is the only recommended treatment (6) for pregnant women ...
Read More Bicillin L-A® Shortage: Recommendations for Healthcare Organizations

There is currently a drug shortage of Penicillin G benzathine injectable suspension products (Bicillin L-A®) listed on the FDA’s drug shortage webpage. The limited supply is primarily due to increased demand, and we are also aware that Penicillin G procaine has been discontinued by the manufacturer. To ensure the appropriate use of the available inventory ...
Read More NEW! Guidance Document for Healthcare Workers: Clinical Reminders During Bicillin L-A® Shortage

As of January 1, 2019, Hawaii State Medicaid (MedQUEST) has removed requirements on fibrosis and sobriety in its guidance for hepatitis C medications. This is in alignment with recommendations from the American Association for the Study of Liver Diseases, and it will provide more people access to life-saving treatment. We will continue to work with ...
Read More Hep Treatment Access Expanded!